2022 annual financial data
Inovio Pharmaceuticals 2022 Net margin
Direct answer
Net margin was -2,726.67%.
Operating income was -267,573,520 USD and net income was -279,818,065 USD.
Operating cash flow was -216,215,421 USD.
Get free Inovio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,262,268 USD
- Operating income
- -267,573,520 USD
- Net income
- -279,818,065 USD
- Operating cash flow
- -216,215,421 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Inovio Pharmaceuticals financial years